<code id='ED8E514781'></code><style id='ED8E514781'></style>
    • <acronym id='ED8E514781'></acronym>
      <center id='ED8E514781'><center id='ED8E514781'><tfoot id='ED8E514781'></tfoot></center><abbr id='ED8E514781'><dir id='ED8E514781'><tfoot id='ED8E514781'></tfoot><noframes id='ED8E514781'>

    • <optgroup id='ED8E514781'><strike id='ED8E514781'><sup id='ED8E514781'></sup></strike><code id='ED8E514781'></code></optgroup>
        1. <b id='ED8E514781'><label id='ED8E514781'><select id='ED8E514781'><dt id='ED8E514781'><span id='ED8E514781'></span></dt></select></label></b><u id='ED8E514781'></u>
          <i id='ED8E514781'><strike id='ED8E514781'><tt id='ED8E514781'><pre id='ED8E514781'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:fashion    Page View:846
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In